Mirae Asset Global ETFs Holdings’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$891K Sell
11,449
-3,195
-22% -$218K ﹤0.01% 1695
2026
Q1
$934K Buy
14,644
+3,014
+26% +$212K ﹤0.01% 1554
2025
Q4
$785K Sell
11,630
-1,907
-14% -$128K ﹤0.01% 1655
2025
Q3
$993K Sell
13,537
-667
-5% -$44.3K ﹤0.01% 1494
2025
Q2
$741K Sell
14,204
-71,574
-83% -$4.07M ﹤0.01% 1596
2025
Q1
$5.47M Sell
85,778
-309
-0.4% -$17.9K 0.01% 734
2024
Q4
$4.12M Buy
86,087
+3,874
+5% +$199K 0.01% 837
2024
Q3
$4.7M Buy
82,213
+5,633
+7% +$323K 0.01% 786
2024
Q2
$4.01M Buy
+76,580
New +$3.36M 0.01% 820

Other funds holding HALO

Mirae Asset Global ETFs Holdings's HALO Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings reduced its Halozyme (HALO) stake by 22% in Q2 2026, selling an estimated $218K and leaving 11,449 shares worth $891K. The position accounts for ﹤0.01% of the portfolio, ranked #1695.

Mirae Asset Global ETFs Holdings first reported a position in HALO in Q2 2024 and has held it in 9 quarters since. The position peaked at $5.47M in Q1 2025. 674 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 11,449 shares of Halozyme worth $891K as of Q2 2026.
  • Mirae Asset Global ETFs Holdings sold 3,195 Halozyme shares in Q2 2026, an estimated $218K.
  • Halozyme made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #1695 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Halozyme in Q2 2024 and has held it in 9 quarters since.
  • Mirae Asset Global ETFs Holdings's Halozyme position peaked at $5.47M in Q1 2025.
  • 674 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.